Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alice Morigi
Observed names:
A Morigi,
A. Morigi,
A. morigi,
Morigi, Alice
Observed institutions:
Ospedale "Santa Maria delle Croci" di Ravenna,
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto di Ematologia di Bologna,
University of Bologna
OpenAlex ID:
A5111328092
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience
2021
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Cancers
·
35
PDF
Spinal Infection Multidisciplinary Management Project (SIMP): From Diagnosis to Treatment Guideline
2011
·
A. Gasbarrini
, L. Boriani
, et al.
·
International Journal of Immunopathology and Pharmacology
·
34
Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma
2020
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Cancer Medicine
·
28
PDF
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30‐year experience
2021
·
Alessandro Broccoli
, Lisa Argnani
, et al.
·
American Journal of Hematology
·
19
PDF
Bendamustine‐rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients
2020
·
Alice Morigi
, Lisa Argnani
, et al.
·
Hematological Oncology
·
19
Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients
2016
·
Letizia Gandolfi
, Cinzia Pellegrini
, et al.
·
The Oncologist
·
19
90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow‐up of 7 years
2016
·
Beatrice Casadei
, Cinzia Pellegrini
, et al.
·
Cancer Medicine
·
19
PDF
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma
2018
·
Alessandro Broccoli
, Beatrice Casadei
, et al.
·
Oncotarget
·
17
PDF
The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients
2017
·
Alessandro Broccoli
, Beatrice Casadei
, et al.
·
BMC Cancer
·
16
PDF
Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life Experience
2021
·
Alessandro Broccoli
, Lisa Argnani
, et al.
·
Journal of Clinical Medicine
·
14
PDF
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia
2021
·
Alessandro Broccoli
, Carolina Terragna
, et al.
·
Hematological Oncology
·
13
PDF
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients
2020
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Annals of Hematology
·
11
PDF
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real‐life experience
2020
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Hematological Oncology
·
11
Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma
2020
·
Alice Morigi
, Beatrice Casadei
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
9
PD-1 blockade as bridge to allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series
2019
·
Beatrice Casadei
, Alessandro Broccoli
, et al.
·
Haematologica
·
9
PDF
90Y‐ibritumomab tiuxetan in patients with extra‐nodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma) — The Zeno Study
2020
·
Ginevra Lolli
, Lisa Argnani
, et al.
·
British Journal of Haematology
·
7
PDF
Spontaneous remission of follicular lymphoma
2019
·
Alice Morigi
, Beatrice Casadei
, et al.
·
Hematological Oncology
·
6
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma
2024
·
Camilla Mazzoni
, Lisa Argnani
, et al.
·
European Journal Of Haematology
·
4
PDF
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
2022
·
Vittorio Stefoni
, Lisa Argnani
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
4
PDF
Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation
2021
·
Alice Morigi
, Vittorio Stefoni
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
4
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia
2019
·
Alessandro Broccoli
, Clara Bertuzzi
, et al.
·
OncoTargets and Therapy
·
4
PDF
Granulomatous tattoo reaction in a nivolumab-treated patient
2020
·
Alessandro Pileri
, Michela Starace
, et al.
·
Giornale Italiano di Dermatologia e Venereologia
·
3
90y‐ibritumomab Tiuxetan in Patients With Extra‐nodal Marginal Zone B‐cell Lymphoma of Mucosa Associated Lymphoid Tissue (malt Lymphoma) – the Zeno Study
2019
·
M. Marangon
, A. Morigi
, et al.
·
Hematological Oncology
·
2
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies
2019
·
Laura Nanni
, Alice Morigi
, et al.
·
Hematological Oncology
·
2
The Berlin‐Frankfurt‐Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience
2018
·
Miriam Marangon
, Lorenzo Tonialini
, et al.
·
American Journal of Hematology
·
2
PDF
Show more works
View as search
Works count:
46
Citation count:
314
H-index:
11
I10-index:
13
Year
Topic
Type